Related Experiment Video

Updated: Oct 10, 2026

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice
06:48

Transplantation of Tail Skin to Study Allogeneic CD4 T Cell Responses in Mice

Published on: July 25, 2014

CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants

M P Fischbein1, A Ardehali, J Yun

  • 1Department of Microbiology, Immunology, and Molecular Genetics, Division of Cardiothoracic Surgery, University of California Los Angeles School of Medicine, Los Angeles, CA 90095, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|December 20, 2000
PubMed

Insights

Chronic rejection in heart transplants depends on CD4+ lymphocytes. Activating CD40 signaling bypasses this requirement, highlighting a potential therapeutic target for transplant rejection.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Molecular Medicine

Background:

  • Chronic rejection is a primary barrier to long-term heart transplant survival.
  • The precise cellular and molecular mechanisms driving chronic rejection remain largely unknown.
  • CD4+ lymphocytes are implicated in mediating transplant rejection, but the exact mechanisms are unclear.

Purpose of the Study:

  • To elucidate the functional role of CD4+ lymphocytes in chronic heart transplant rejection.
  • To investigate alternative pathways that can drive rejection independently of CD4+ lymphocytes.
  • To explore the potential of targeting CD40 signaling for therapeutic intervention in transplant rejection.

Main Methods:

  • Utilized a murine heterotopic heart transplant model without immunosuppression.
  • Employed CD4 knockout and CD28 knockout recipient mice.
  • Administered a CD40-activating monoclonal antibody (mAb FGK45) to assess its impact on rejection.

Main Results:

  • Chronic rejection was strictly dependent on the presence of CD4+ lymphocytes in an MHC class II-mismatched model.
  • Activating CD40 signaling with mAb FGK45 induced chronic rejection in CD4 knockout recipients, indicating CD40 can substitute for CD4+ lymphocyte help.
  • This CD40-mediated rejection was CD8+ lymphocyte-dependent and independent of B7-CD28 costimulation.

Conclusions:

  • CD4+ lymphocyte help is essential for chronic heart transplant rejection.
  • CD40 signaling provides a critical pathway that can drive rejection, even in the absence of CD4+ lymphocytes.
  • Targeting CD40 ligand may be a viable strategy to prevent chronic rejection, particularly in specific transplant scenarios requiring CD4+ lymphocyte help.

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Murine Heterotopic Heart Transplant Technique10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...